RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
A Sheikh, S Md, P Kesharwani - Journal of Controlled Release, 2021 - Elsevier
A bird's eye view is now demanded in the area of cancer research to suppress the suffering
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
Oral delivery of RNAi for cancer therapy
Cancer is a major health concern worldwide and is still in a continuous surge of seeking for
effective treatments. Since the discovery of RNAi and their mechanism of action, it has …
effective treatments. Since the discovery of RNAi and their mechanism of action, it has …
[HTML][HTML] Metal-based gels: Synthesis, properties, and applications
G Picci, C Caltagirone, A Garau, V Lippolis… - Coordination Chemistry …, 2023 - Elsevier
This review covers various aspects of recent developments on the design, the synthesis, the
characterization of gels that:(i) are formed in the presence of metal ions (metallogels);(ii) are …
characterization of gels that:(i) are formed in the presence of metal ions (metallogels);(ii) are …
Safety challenges and application strategies for the use of dendrimers in medicine
X Li, A Naeem, S Xiao, L Hu, J Zhang, Q Zheng - Pharmaceutics, 2022 - mdpi.com
Dendrimers are used for a variety of applications in medicine but, due to their host–guest
and entrapment characteristics, are particularly used for the delivery of genes and drugs …
and entrapment characteristics, are particularly used for the delivery of genes and drugs …
Cutting-edge development in dendritic polymeric materials for biomedical and energy applications
Dendritic polymers (dendrimers and hyperbranched polymers) are becoming increasingly
popular due to their vast range of uses. Due to their distinctive and novel qualities, they have …
popular due to their vast range of uses. Due to their distinctive and novel qualities, they have …
Dendrimer platform against prostate cancer: Recent update on new horizon of treatment
M Pandey, HX Lang, JS Loh, YL Chai, HL Tee… - Journal of Drug Delivery …, 2023 - Elsevier
Prostate malignancy is regarded as one of the most lethal disorders in men. In the last two
decades, new cases of prostate cancer have risen swiftly worldwide. Currently, the …
decades, new cases of prostate cancer have risen swiftly worldwide. Currently, the …
Engineered dendritic architecture loaded with proton pump inhibitor for antibacterial therapy: Newer solution for gastric upset
A majority of gastric malignancies and peptic ulcers are attributed to Helicobacter pylori (H.
pylori), which affects more than 50% of the world's population. A growing number of new …
pylori), which affects more than 50% of the world's population. A growing number of new …
Hyaluronic acid-protein conjugate modified iron-based MOFs (MIL-101 (Fe)) for efficient therapy of neuroblastoma: Molecular simulation, stability and toxicity studies
Iron-based metal-organic frameworks (MIL (101)) have recently gained attention in materials
science for biomedical applications. In the present work, Iron-based MOF (MIL-101 (Fe)) …
science for biomedical applications. In the present work, Iron-based MOF (MIL-101 (Fe)) …
Engineering of 177Lu-labeled gold encapsulated into dendrimeric nanomaterials for the treatment of lung cancer
Z Wang, M Ye, D Ma, J Shen, F Fang - Journal of Biomaterials …, 2022 - Taylor & Francis
As a novel type of theranostic radioactive agents, 177Lu-labeled nanomaterials conjugated
to macromolecules have been described. The study aimed to fabricate PAMAM-G4–(177Lu …
to macromolecules have been described. The study aimed to fabricate PAMAM-G4–(177Lu …
Expatiating the pivotal role of Dendrimers as emerging nanocarrier for management of Liver Disorders
Despite advancements in medical science, liver disorders remain to be significant global
health challenge, and drug toxicity frequently makes pharmacological therapy difficult …
health challenge, and drug toxicity frequently makes pharmacological therapy difficult …